Pursuant to Regulation 30 and Para (A) of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Epigral has informed about Investor / Analyst Plant Visit on 6th March, 2024.
The above information is a part of company’s filings submitted to BSE.